Oscar Health financials
$29.77+0.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.59B | $2.76B | $2.93B | $2.86B | $3.00B | $2.35B | $2.37B | $2.17B | $2.10B | $1.28B | $1.44B |
| Gross profit | $1.09B | $1.36B | $135.6M | $346.4M | $311.0M | $740.5M | $284.9M | $369.2M | $460.6M | $544.5M | $71.0M | $276.8M |
| Gross margin | 22.2% | 29.6% | 4.9% | 11.8% | 10.9% | 24.7% | 12.1% | 15.6% | 21.2% | 25.9% | 5.6% | 19.2% |
| Operating income | $388.6M | $643.5M | -$383.4M | -$182.5M | -$230.5M | $251.0M | -$190.2M | -$98.7M | $17.8M | $142.6M | -$300.9M | -$58.2M |
| Net income | $361.8M | $679.0M | -$352.6M | -$137.4M | -$228.4M | $275.3M | -$153.5M | -$54.6M | $56.2M | $177.4M | -$150.0M | -$65.4M |
| Net margin | 7.4% | 14.8% | −12.8% | −4.7% | −8.0% | 9.2% | −6.5% | −2.3% | 2.6% | 8.4% | −11.8% | −4.5% |
| Diluted EPS | $1.10 | $2.07 | $-1.54 | $-0.53 | $-0.89 | $0.92 | $-0.69 | $-0.22 | $0.20 | $0.62 | $-0.66 | $-0.29 |
| EBITDA | $394.7M | $650.5M | -$375.5M | -$175.2M | -$223.5M | $257.7M | -$180.9M | -$91.2M | $25.4M | $150.4M | -$300.9M | -$49.1M |
| Operating cash flow | $2.09B | $2.62B | $671.9M | -$964.7M | $509.1M | $878.5M | $346.8M | -$500.1M | $497.2M | $634.4M | $296.9M | -$1.15B |
| Free cash flow | $2.08B | $2.61B | $662.8M | -$973.7M | $499.8M | $869.5M | $340.0M | -$507.7M | $489.6M | $628.4M | $290.8M | -$1.16B |
| Diluted shares | 333.4M | 329.8M | 228.8M | 259.3M | 255.5M | 305.9M | 222.5M | 243.1M | 304.0M | 293.8M | 227.2M | 223.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B |
| Short-term investments | $4.48B | $1.99B | $1.22B | $887.6M | $938.1M | $751.5M |
| Total debt | $431.6M | $430.9M | $430.1M | $686.3M | $299.9M | $299.7M |
| Total assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B |
| Total liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B |
| Shareholders' equity | $2.06B | $1.67B | $980.7M | $1.03B | $1.16B | $1.34B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology